Obama proposes seven year rule for biologics
September 21, 2011Research and Development, Sales and Marketing Obama, biologics
President Obama has returned to the issue of market exclusivity for biologic drugs as a way of cutting healthcare costs. …
Silence Therapeutics appoints Thomas Christely
September 21, 2011Research and Development appointment, research and development
UK-headquartered biotech Silence Therapeutics has appointed Thomas Christély as chief executive. He was instrumental in the merger of Silence Therapeutics …
Pfizer to invest $200m in Irish biomanufacturing plant
September 21, 2011Manufacturing and Production Ireland, Pfizer, pharma manufacturing news
Pfizer is planning to invest around €145 million ($200m) at its biomanufacturing facility in Co Dublin, Ireland, according to the …
Janssen’s Zytiga launched in the UK
September 21, 2011Sales and Marketing Zytiga, prostate cancer
Janssen’s new advanced prostate cancer treatment Zytiga has been launched in the UK. Zytiga (abiraterone acetate) has been shown in …
Pharmacovigilance Compliance Report submission; MHRA’s Risk Based Compliance Programme
September 20, 2011Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing PV, Wainwright Associates
A new version of the MHRA pharmacovigilance Compliance Report (Good Pharmacovigilance Practice Questionnaire) has been released by the MHRA.Submission of …
Roche to show new cancer data at European congress
September 20, 2011Research and Development Cancer, Roche, T-DM1, Zelboraf, avastin
Roche will highlight a range of new approaches in targeting cancer at the upcoming European cancer conference. In a series …
Boehringer’s Trajenta launched in the UK
September 20, 2011Sales and Marketing Boehringer, Trajenta, diabetes
Boehringer Ingelheim has launched its new diabetes drug Trajenta in the UK, with a price tag to match its rival …
Teva makes commitment to Russian manufacturing facility
September 20, 2011Manufacturing and Production, Sales and Marketing Russia, Teva
Teva has joined a number of its peers in the pharmaceutical sector and announced plans to build a new manufacturing …
Intersex fish add to concerns about pharma wastewater
September 20, 2011Business Services, Manufacturing and Production Contamination, pharma manufacturing news
Researchers in France have discovered that wild fish living downstream from a pharmaceutical production plant making steroid drugs show serious …
Merck licences new MS drug
September 19, 2011Research and Development Cladribine, Merck KGaA, Merck Serono, PI-2301
Merck KGaA has in-licensed a new multiple sclerosis drug and aims to start it in phase II studies later this …
Alkermes and Elan Drug Technologies complete merger
September 19, 2011Manufacturing and Production Alkermes, Elan, pharma manufacturing news
The contract manufacturing and development unit of Irish drugmaker Elan has completed a near-$1 billion merger with drug delivery specialist …
Dr Arvind Hundal joins Zealand Pharma
September 19, 2011Sales and Marketing appointment, sales and marketing
Zealand Pharma has boosted its executive management team with the appointment of Dr Arvind Hundal as chief business officer. She …
ArcMedia appoints communications coaches
September 19, 2011Medical Communications, Sales and Marketing appointment, medical communications, sales and marketing
UK speaker training agency ArcMedia has appointed new communications consultants Linda Gummery and Charlotte Hume. Linda spent eight years leading …
Working Life: Graham Morris from BMS
September 19, 2011Sales and Marketing Working Life
Bristol-Myers Squibb’s CV/Metabolics business unit director Graham Morris on how his field is changing and the best, and worst, things …
Cancer Fund improving treatment access
September 19, 2011Sales and Marketing Cancer Drugs Fund, postcode prescribing
The Cancer Drugs Fund is dramatically improving access to new cancer medicines for patients in England – but its success …
Melanoma: new treatments and hopes
September 19, 2011Research and Development advanced melanoma, melanoma, skin cancer
It usually starts with a subtle change of colour or shape in an existing mole. But if left undiagnosed and …
Eliquis launched in the UK
September 19, 2011Sales and Marketing Eliquis, Pradaxa, VTE, Xarelto
Eliquis, the latest entrant to the competitive oral anticoagulant market, has been launched in the UK.Co-developed and co-marketed by Pfizer …
McLaren alliance to turbocharge GSK research
September 16, 2011Manufacturing and Production, Research and Development GSK, manufacturing and production news, pharma manufacturing news, research and development news
GlaxoSmithKline has turned to the engineering expertise of Formula 1 racing team McLaren in an innovative alliance designed to transform …
UK-funded science research must be made more accessible, says minister
September 16, 2011Medical Communications, Research and Development UK science
Research paid for by the UK taxpayer must be made more accessible to the public, researchers and other stake holders, …
Positive results for phase II malaria vaccine
September 16, 2011Research and Development malaria, malaria vaccine
Researchers in the US and West Africa believe they have identified the first effective blood-stage malaria vaccine, a development which …
Latest content
Five Facts about NHS and primary care
AI in pharma: From lab development to patient impact
